News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

State Appeals Court Reverses Preempted Medtronic, Inc. (MDT) InFuse Case


2/10/2014 8:37:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A California appeals court overturns the preemption of a product liability lawsuit filed against Medtronic over its controversial InFuse bone-growth protein. A California appeals court this week reanimated a product liability lawsuit filed over Medtronic's (NYSE:MDT) controversial InFuse bone-growth protein, reversing a lower court's decision that federal regulations in this case preempt state rules. The preemption doctrine is based on a U.S. Supreme Court ruling that state laws that differ from or add to federal regulations are trumped by the federal rules.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at Star Tribune

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES